drugset / Trial / NCT07000695

Managed Access Programs for TQJ230, Pelacarsen

NCT07000695

Expanded access Available Novartis Pharmaceuticals

Summary

The purpose of this registration is to list Managed Access Programs (MAPs) related to TQJ230, pelacarsen

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Pelacarsen Antisense oligonucleotide